Drug intelligence / Profile preview

Uromannosa

Development stage: Unknown
Lead developer: Laboratorios Q Pharma
Modality: Small Molecules
Administration: Oral

Overview

Uromannosa is an oral food supplement developed by Laboratorios Q Pharma, specifically formulated for the management and prevention of recurrent urinary tract infections (UTIs) and cystitis. The product contains a combination of D-Mannose (2000 mg), a patented cranberry extract (Cranmax) providing 36 mg of type A proanthocyanidins (PACs), and Vitamin D3 (Colecalciferol). D-Mannose acts by binding to the FimH adhesin of *Escherichia coli*, preventing the bacteria from adhering to the urinary tract mucosa. The cranberry PACs provide a synergistic anti-adherent effect against uropathogens, while Vitamin D3 supports the immune system's response. It is presented as powder sachets for oral administration and is suitable for diabetics and celiacs.

Brand names: UromannosaUromann

Targets

FimH (Type 1 fimbrial adhesin)

Beyond the preview

Go deeper on Uromannosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uromannosa.

Explore the full profile